ADENOVIRUS-MEDIATED TRANSFER OF THE ACID ALPHA-GLUCOSIDASE GENE INTO FIBROBLASTS, MYOBLASTS AND MYOTUBES FROM PATIENTS WITH GLYCOGEN-STORAGE-DISEASE TYPE-II LEADS TO HIGH-LEVEL EXPRESSION OF ENZYME AND CORRECTS GLYCOGEN ACCUMULATION
Mp. Nicolino et al., ADENOVIRUS-MEDIATED TRANSFER OF THE ACID ALPHA-GLUCOSIDASE GENE INTO FIBROBLASTS, MYOBLASTS AND MYOTUBES FROM PATIENTS WITH GLYCOGEN-STORAGE-DISEASE TYPE-II LEADS TO HIGH-LEVEL EXPRESSION OF ENZYME AND CORRECTS GLYCOGEN ACCUMULATION, Human molecular genetics (Print), 7(11), 1998, pp. 1695-1702
Glycogen storage disease type II (GSD II) is an autosomal recessive di
sorder caused by defects in the lysosomal acid alpha-glucosidase (GAA)
gene. We investigated the feasibility of using a recombinant adenovir
us containing the human GAA gene under the control of the cytomegalovi
rus promoter (AdCMV-GAA) to correct the enzyme deficiency in different
cultured cells from patients with the infantile form of GSD II. In GA
A-deficient fibroblasts infected with AdCMV-GAA, transduction and tran
scription of the human transgene resulted in de novo synthesis of GAA
protein. The GAA enzyme activity was corrected from the deficient leve
l to 12 times the activity of normal cells, The transduced cells overe
xpressed the 110 kDa precursor form of GAA, which was secreted into th
e culture medium and was taken up by recipient cells. The recombinant
GAA protein was correctly processed and was active on both an artifici
al substrate 4-methylumbellifer yl-alpha-D-glucopyranoside (4MUG) and
glycogen, In GAA-deficient muscle cells, a significant increase in cel
lular enzyme level, similar to 20-fold higher than in normal cells, wa
s also observed after viral treatment. The transduced muscle cells wer
e also able to efficiently secrete the recombinant GAA, Moreover, tran
sfer of the human transgene resulted in normalization of cellular glyc
ogen content with clearance of glycogen from lysosomes, as assessed by
electron microscopy, in differentiated myotubes, These results demons
trate phenotypic correction of cultured skeletal muscle from a patient
with infantile-onset GSD II using a recombinant adenovirus, We conclu
de that adenovirus-mediated gene transfer might be a suitable model sy
stem for further in vivo studies on delivering GAA to GSD II muscle, n
ot only by direct cell targeting but also by a combination of secretio
n and uptake mechanisms.